NDC 62559-650

ATACAND HCT

Candesartan Cilexetil And Hydrochlorothiazide

ATACAND HCT is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Candesartan Cilexetil; Hydrochlorothiazide.

Product ID62559-650_8e6768a6-bb5c-4d0b-a535-98b38b0a306a
NDC62559-650
Product TypeHuman Prescription Drug
Proprietary NameATACAND HCT
Generic NameCandesartan Cilexetil And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-10-01
Marketing CategoryNDA / NDA
Application NumberNDA021093
Labeler NameANI Pharmaceuticals, Inc.
Substance NameCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Active Ingredient Strength16 mg/1; mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 62559-650-90

90 TABLET in 1 BOTTLE (62559-650-90)
Marketing Start Date2018-10-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62559-650-90 [62559065090]

ATACAND HCT TABLET
Marketing CategoryNDA
Application NumberNDA021093
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-10-01

Drug Details

Active Ingredients

IngredientStrength
CANDESARTAN CILEXETIL16 mg/1

OpenFDA Data

SPL SET ID:d91152c4-66ba-466f-b4f9-0da628d42b1d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 802749
  • 805863
  • 578330
  • 578325
  • 805859
  • 805855
    • UPC Code
  • 0362559650908
  • 0362559652902
  • 0362559651905

    • Pharmacological Class

    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "ATACAND HCT" or generic name "Candesartan Cilexetil And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0186-0162ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
    0186-0322ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
    0186-0324ATACAND HCTCandesartan cilexetil Hydrochlorothiazide
    62559-650ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    62559-651ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    62559-652ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
    63629-3377ATACAND HCTATACAND HCT
    0378-3001Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    0378-3002Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    0378-3003Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    33342-131Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    33342-132Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    33342-133Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    43547-459candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    43547-460candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    43547-461candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
    62559-660Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    62559-661Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
    62559-662Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide

    Trademark Results [ATACAND HCT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ATACAND HCT
    ATACAND HCT
    75250934 2485478 Live/Registered
    ASTRAZENECA AB
    1997-03-03
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.